Back
Vertex Pharmaceuticals Stock Price Chart
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
40
VRTX
Vertex Pharmaceuticals
Last Price:
$425.10
Seasonality Move:
9.28%
7 Day Trial
ALL ACCESS PASS
$
7
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing selling pressure, which indicates risk of future bearish movement.
Vertex Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 468.64 | Sell |
| 20-day SMA: | 482.57 | Sell |
| 50-day SMA: | 488.34 | Sell |
| 200-day SMA: | 470.43 | Sell |
| 8-day EMA: | 456.79 | Sell |
| 20-day EMA: | 474.57 | Sell |
| 50-day EMA: | 479.38 | Sell |
| 200-day EMA: | 464.57 | Sell |
Vertex Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -11.62 | Sell |
| Relative Strength Index (14 RSI): | 26.08 | Sell |
| Chaikin Money Flow: | -1580710 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (458.48 - 503.98) | Sell |
| Bollinger Bands (100): | (430.51 - 498.91) | Sell |
Vertex Pharmaceuticals Technical Analysis
| Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Vertex Pharmaceuticals Stock
Is Vertex Pharmaceuticals Stock a Buy?
-
Vertex Pharmaceuticals share price is 424.99 while VRTX 8-day simple moving average is 468.64, which is a Sell signal.
-
The stock price of VRTX is 424.99 while Vertex Pharmaceuticals 20-day SMA is 482.57, which makes it a Sell.
-
Vertex Pharmaceuticals 50-day simple moving average is 488.34 while VRTX share price is 424.99, making it a Sell technically.
-
VRTX stock price is 424.99 and Vertex Pharmaceuticals 200-day simple moving average is 470.43, creating a Sell signal.
VRTX Technical Analysis vs Fundamental Analysis
Sell
40
Vertex Pharmaceuticals (VRTX)
is a Sell
Is Vertex Pharmaceuticals a Buy or a Sell?
-
Vertex Pharmaceuticals stock is rated a SellThe current Vertex Pharmaceuticals [VRTX] share price is $424.99. The Score for VRTX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Vertex Pharmaceuticals Stock Info
Market Cap:
109.1B
Price in USD:
424.99
Share Volume:
1.6M
Vertex Pharmaceuticals 52-Week Range
52-Week High:
519.88
52-Week Low:
377.85
Sell
40
Vertex Pharmaceuticals (VRTX)
is a Sell
Vertex Pharmaceuticals Share Price Forecast
-
What is the Vertex Pharmaceuticals stock price today?The Vertex Pharmaceuticals stock price is 424.99 USD today.
-
Will VRTX stock go up or go down?Vertex Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Vertex Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Vertex Pharmaceuticals is overvalued.
Is Vertex Pharmaceuticals Stock a Buy?
-
Vertex Pharmaceuticals share price is 424.99 while VRTX 8-day exponential moving average is 456.79, which is a Sell signal.
-
The stock price of VRTX is 424.99 while Vertex Pharmaceuticals 20-day EMA is 474.57, which makes it a Sell.
-
Vertex Pharmaceuticals 50-day exponential moving average is 479.38 while VRTX share price is 424.99, making it a Sell technically.
-
VRTX stock price is 424.99 and Vertex Pharmaceuticals 200-day simple moving average is 464.57, creating a Sell signal.
Fundamental Analysis of Vertex Pharmaceuticals
Is Vertex Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.46 per share, an increase next quarter of $0.39 per share, an increase this year of $17.52 per share, and an increase next year of $2.66 per share.
Technical Analysis of Vertex Pharmaceuticals
Should I short Vertex Pharmaceuticals stock?
-
VRTX Moving Average Covergence Divergence (MACD) indicator is -11.62, suggesting Vertex Pharmaceuticals is a Sell
-
Vertex Pharmaceuticals Relative Strength Index (RSI) is 26.08, which suggest Vertex Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Vertex Pharmaceuticals is (458.48 - 503.98), which suggest Vertex Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Vertex Pharmaceuticals is (430.51 - 498.91), which suggest Vertex Pharmaceuticals is a Sell
* Vertex Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.